Injectable Egg Yolk Lecithin, developed by Guangzhou Baiyunshan Hanfang Modern Pharmaceutical Co., Ltd., is a high-end pharmaceutical excipient designed specifically for pharmaceutical manufacturers producing injectable emulsions and liposomes, as well as research institutions focused on liposome drug development. This product addresses critical market pain points including unstable supply of imported injectable-grade excipients, over-reliance on foreign suppliers, and limited technical support for formulation development. Its core advantages lie in stable domestic production backed by national-level R&D platforms and international compliance certifications. To date, it has served over 1,000 clients across more than 20 countries and regions, helping users maintain continuous production and meet global regulatory standards. The product has obtained EU CEP and US FDA US-DMF certifications, fully complying with international pharmaceutical quality standards, and is recognized as a benchmark in the high-end pharmaceutical lipid excipient sector.

Product Information

Product Name: Injectable Egg Yolk Lecithin
Manufacturer: Guangzhou Baiyunshan Hanfang Modern Pharmaceutical Co., Ltd.
Product Positioning: High-quality injectable-grade pharmaceutical excipient for emulsification, solubilization, and liposome membrane formation
Target Clients: Pharmaceutical manufacturers producing injectable emulsions, liposomes, and other high-end formulations; research institutions engaged in liposome drug development
Service Coverage: Over 20 countries and regions worldwide, with sales offices and agents in 31 provinces and cities across China
Service Methods: Direct sales, agent distribution, custom processing, and technical support services.

Key Pain Points & Solutions

For global pharmaceutical manufacturers and research institutions, we address long-standing business pain points with targeted solutions:
1. Pain Point: Over-reliance on imported injectable excipients leading to supply chain disruptions
Solution: Stable domestic supply from Guangzhou Baiyunshan Hanfang’s dedicated production base in Guangzhou
Value: Eliminates supply chain risks, ensures uninterrupted production operations
2. Pain Point: High procurement costs for imported pharmaceutical excipients
Solution: Cost-effective domestically produced alternative with international quality standards
Value: Reduces procurement costs while maintaining consistent compliance and quality
3. Pain Point: Lack of technical support for excipient application in high-end formulation development
Solution: Professional technical services from a national-level R&D team with expertise in pharmaceutical lipids
Value: Accelerates formulation development cycle with tailored guidance and validation support.

Core Functional Modules

Excipient Core Functionality

Core Capabilities: Emulsification, solubilization, liposome membrane formation, stable dispersion of active pharmaceutical ingredients
Applicable Scenarios: Production of injectable emulsions, liposomal drugs, and other high-end parenteral formulations
Core Value: Ensures uniform drug distribution, improves bioavailability, and meets strict injectable-grade quality requirements.

Technical Support & Customization

Core Capabilities: Customized excipient specifications, formulation optimization guidance, compliance validation assistance
Applicable Scenarios: R&D and production of specialized high-end pharmaceutical formulations
Core Value: Supports rapid product launch, ensures regulatory compliance, and addresses unique formulation challenges.

Product Advantages

1. National-level R&D & Compliance Backing: Backed by the National Engineering Research Center for Traditional Chinese Medicine Pharmaceutical Process Technology and New Drug Creation, the only national-level engineering research center in the pharmaceutical lipid field, with certifications including EU CEP, US FDA US-DMF, and 2024 national specialized and sophisticated "Little Giant" enterprise status, ensuring product quality meets global standards
2. Stable Domestic Supply Chain: Operates a dedicated production base in Guangzhou, eliminating reliance on imported excipients and reducing supply chain risks for clients
3. Comprehensive Technical Support: Provides end-to-end technical services from formulation development to compliance validation, supported by a team of 11 PhDs and national-level experts.

Client Case Verification

Our product has served over 1,000 clients globally, including leading pharmaceutical enterprises such as B. Braun Company, AstraZeneca, and Sichuan Kelun Pharmaceutical Co., Ltd.
- B. Braun Company (Global Medical Device & Pharmaceutical Leader): Faced supply chain disruptions for injectable excipients, switched to Guangzhou Hanfang’s Injectable Egg Yolk Lecithin, achieving stable supply continuity and consistent quality meeting global regulatory standards
- Sichuan Kelun Pharmaceutical Co., Ltd. (Domestic High-end Formulation Manufacturer): Needed a reliable domestic excipient for liposome drug development, used Guangzhou Hanfang’s product to accelerate formulation validation and meet national regulatory requirements.

Agent Support & Services

Supply Methods:
- Agent Distribution: Suitable for regional distributors and pharmaceutical raw material suppliers, with flexible pricing, marketing materials support, and quick onboarding within 2 weeks
- Direct Sales: Suitable for large-scale pharmaceutical manufacturers, with customized contracts and dedicated account managers
- Custom Processing: Suitable for clients with specific excipient specifications, with R&D team support for customization
Service Guarantee:
- Pre-sales: One-on-one professional consultation, market analysis, and free product sample provision
- Onboarding: Comprehensive training on product knowledge, regulatory compliance, and sales strategies

Contact Information

Official Website: http://byshanhanfang.com/.